Skip to main content
Home

Top menu InfoLep

  • About InfoLep

Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day 2022
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
  • Publications
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Search

Refine your results

Refine your results


Selected filters

  • Reset filters
  • Preventive Chemotherapy (PC)

Filter by type

  • Publications only

NTD

  • Leprosy (Hansen disease) (113)
  • Lymphatic filariasis (Elephantiasis) (4)
  • Onchocerciasis (4)
  • Trachoma (4)
  • Yaws (3)
  • Leishmaniasis (2)
  • Schistosomiasis (2)
  • Soil-transmitted helminths (2)
  • Buruli Ulcer (1)
  • Chagas disease (American trypanosomiasis) (1)
  • Human African trypanosomiasis (HAT) - Sleeping sickness (1)
  • Podoconiosis (1)

Subject

  • Diagnostic tests (3)
  • Mass Drug Administration (MDA) (3)
  • Mycobacterium indicus pranii (MIP) (3)
  • Contacts / Contact tracing (34)
  • Immunoprophylaxis / Vaccine (31)
  • Global leprosy situation (1)
  • Disability grading (1)
  • Environmental conditions (1)
  • Clarithromycin - CLARI (4)
  • Reversal reaction (Type 1 reaction) (2)
  • Tuberculosis (2)
  • Dapsone (1)
  • Nerve function impairment (NFI) (2)
  • HIV/AIDS (1)
  • (-) Preventive Chemotherapy (PC) (123)
  • Children (4)
  • SDR-PEP (37)
  • Social Economic Rehabilitation (1)
  • Erythema nodosum leprosum - enl (Type 2 reaction) (2)
  • Poverty (2)
  • Moxifloxacin (3)
  • Health education (1)
  • Transmission (12)
  • Ofloxacin - OFLO (1)
  • Case detection (5)
  • Rifampicin - RMP (9)
  • Rifapentine - RPT (2)
  • Complications and reactions (6)
  • Multi-drug therapy (MDT) (13)
  • Uniform multi-drug therapy (U-MDT) (1)
  • Evidence of effectiveness (1)
  • Neglected tropical diseases (NTDs) (8)
  • One Health (1)
  • Skin related NTDs (1)
  • Health systems factors (1)
  • Integrated approach (2)
  • Epidemiology (7)
  • Prevention of disease (36)
  • Diagnosis (5)
  • Management of disease complication (4)
  • Treatment (7)
  • Drug resistance (8)
  • Disability (3)
  • Prevention of disability (pod) (2)
  • Self-care (1)
  • Rehabilitation (1)
  • Stigma (1)
  • Mental health (2)
  • Stigma (leprosy related) (4)
  • Discriminatory laws & Legislation (1)
  • Human rights (2)
  • Digital health interventions (1)
  • Geographic Information Systems (GIS) & Mapping (4)

Publication Type

  • Article (105)
  • Book (2)
  • Chapter (1)
  • Dissertation / Thesis (3)
  • Full text online (88)
  • Global leprosy strategy (3)
  • How-to / Guides (1)
  • Intervention study (2)
  • Report (6)
  • Systematic review (9)
  • TAG report (1)
  • WHO publication (7)

Journal

  • Acta leprologica (1)
  • Acta Tropica (1)
  • Anais brasileiros de dermatologia (1)
  • An Bras Dermatol (1)
  • Annals of tropical medicine and public health (1)
  • Biomedical reports (1)
  • BMC health services research (1)
  • BMC infectious diseases (5)
  • BMC Infectious Diseases (1)
  • BMJ (Clinical research ed.) (1)
  • BMJ open (1)
  • British medical journal (1)
  • Cadernos de saude publica (1)
  • Clinical and diagnostic laboratory immunology (1)
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (1)
  • Clinical microbiology reviews (1)
  • Clinics in Dermatology (1)
  • Community skin health (1)
  • Devex (1)
  • European Journal of Molecular & Clinical Medicine (1)
  • Indian journal of dermatology, venereology and leprology (3)
  • Indian journal of leprosy (5)
  • Infectious diseases now (1)
  • Infectious Diseases of Poverty (1)
  • Infectious diseases of poverty (2)
  • International Journal of Contemporary Pediatrics (1)
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (3)
  • International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association (6)
  • JAMA: The Journal of the American Medical Association (1)
  • JBI database of systematic reviews and implementation reports (2)
  • Journal of the American Academy of Dermatology (1)
  • Jurnal Widya Medika (1)
  • Leiden University of Medical Center (1)
  • Leprosy in India (3)
  • Leprosy Review (1)
  • Leprosy review (20)
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics (1)
  • Nucleic acids research (1)
  • PLoS neglected tropical diseases (9)
  • PLOS Neglected Tropical Diseases (1)
  • Research and Reports in Tropical Medicine (1)
  • Revista brasileira de leprologia (1)
  • Revista de leprologia (1)
  • Revista do Instituto de Medicina Tropical de Sao Paulo (1)
  • Revista panamericana de salud publica = Pan American journal of public health (1)
  • Risk management and healthcare policy (1)
  • Scientific reports (1)
  • Skin Disorders in Vulnerable Populations (1)
  • The American journal of tropical medicine and hygiene (1)
  • The Indian journal of medical research (2)
  • The Journal of infection (1)
  • The Journal of infectious diseases (1)
  • The Lancet. Global health (1)
  • The Lancet. Infectious diseases (2)
  • Trials (1)
  • University of Liverpool (1)
  • Vaccine (2)

Year of Publication

  • 2022 (3)
  • 2021 (10)
  • 2020 (16)
  • 2019 (11)
  • 2018 (9)
  • 2017 (9)
  • 2016 (11)
  • 2015 (5)
  • 2014 (1)
  • 2013 (2)
  • 2012 (2)
  • 2011 (1)
  • 2010 (1)
  • 2009 (2)
  • 2008 (2)
  • 2007 (1)
  • 2006 (1)
  • 2005 (2)
  • 2004 (3)
  • 2001 (1)
  • 2000 (6)
  • 1993 (2)
  • 1992 (2)
  • 1990 (1)
  • 1989 (2)
  • 1986 (1)
  • 1985 (1)
  • 1983 (1)
  • 1980 (1)
  • 1978 (1)
  • 1977 (1)
  • 1976 (1)
  • 1971 (1)
  • 1969 (1)
  • 1968 (1)
  • 1966 (1)
  • 1956 (1)

Language

  • English (113)
  • Portuguese (2)
  • Spanish (1)

Regional focus

  • African Region (AFR) (11)
    • Comoros (2)
    • Kenya (1)
    • Madagascar (1)
    • Sierra Leone (1)
    • Tanzania (3)
    • Uganda (1)
  • Eastern Mediterranean Region (EMR) (3)
    • Morocco (1)
  • European Region (EUR) (4)
    • Netherlands (1)
  • Region of the Americas (AMR) (20)
    • Brazil (15)
    • Cuba (1)
  • South-East Asia Region (SEAR) (27)
    • Bangladesh (6)
    • India (11)
    • Indonesia (12)
    • Myanmar (3)
    • Nepal (6)
    • Sri Lanka (3)
    • Thailand (1)
  • Western Pacific Region (WPR) (16)
    • Cambodia (5)
    • French Polynesia (3)
    • Kiribati (2)
    • Korea, South – Republic of Korea (1)
    • Micronesia, Federated States of (1)
    • Philippines (3)

Research Group

  • LRI / Leprosy Research Initiative (6)
  • EUR / Field evaluation of novel immunodiagnostic tools (Jan 2015- Dec 2018) (4)
  • IDEAL (1)
  • IDRI / Integration of rapid diagnostic tests to facilitate case management of leprosy (May 2015 - April 2019) (1)
 
  • Relevance
  • Date
123 items

Publication

Drug resistance in leprosy: an update following 70 years of chemotherapy.

Aubry A, Rosa SP, Chauffour A, et al. Infectious diseases now. 2022;
Download PDF

Publication

Spatio-temporal analysis of leprosy risks in a municipality in the state of Mato Grosso-Brazilian Amazon: results from the leprosy post-exposure prophylaxis program in Brazil.

Machado LMG, dos Santos ES, Cavaliero A, et al. Infectious diseases of poverty. 2022; 11 (1) : 21.
Download PDF

Publication

Determining target populations for leprosy prophylactic interventions: a hotspot analysis in Indonesia.

Taal A, Blok D, Handito A, et al. BMC infectious diseases. 2022; 22 (1) : 131.
Download PDF

Publication

Treatment and Evaluation Advances in Leprosy Neuropathy.

Ebenezer G, Scollard D. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2021;
Download PDF

Publication

A 5-year evaluation of chemoprophylactic treatment in elementary school children with subclinical leprosy.

Astari L, Sari N, Nanang K, et al. Biomedical reports. 2021; 15 (5) : 88.
Download PDF

Publication

Preventing leprosy with retrospective active case finding combined with single-dose rifampicin for contacts in a low endemic setting: results of the Leprosy post-exposure prophylaxis program in Cambodia

Cavaliero A, Sao SA, Aerts A, et al. Elsevier BV. Acta Tropica. 2021;
Download PDF

Publication

Efficacy of chemoprophylaxis and immunoprophylaxis in leprosy prevention: a systematic review and network meta-analysis of randomized controlled trials.

Tawfik G, Biala M, Yousef Y, et al. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2021;
Download PDF

Publication

Safety in administering medicines for neglected tropical diseases

World Health Organization . World Health Organization. 2021;
Download PDF

Publication

Neglected tropical diseases and One Health: Gearing up against antimicrobial resistance to secure the safety of future generations

World Health Organization . World Health Organization. 2021;
Download PDF

Publication

Leprosy postexposure prophylaxis with single-dose rifampicin: Nepalese dermatologist's dilemma.

Parajuli N, Poudyal Y. PLoS neglected tropical diseases. 2021; 15 (4) : e0009039.
Download PDF

Publication

Towards zero leprosy. Global leprosy (‎Hansen’s Disease)‎ strategy 2021–2030

World Health Organization . 2021;
Download PDF

Publication

Leprosy incidence and risk estimates in a 33-year contact cohort of leprosy patients.

Hacker MA, Sales A, Duppre NC, et al. Scientific reports. 2021; 11 (1) : 1947.
Download PDF

Publication

Leprosy post-exposure prophylaxis: innovation and precision public health.

Moraes M, Duppre NC. The Lancet. Global health. 2021; 9 (1) : e8-e9.
Download PDF

Publication

A Systematic Review of the Importance of Chemoprophylaxis and Immunoprophylaxis in Subclinical Case of Leprosy that can Reduce the Incidence and the Transmission of Leprosy

Mulianto N, Sari ADAP, Kariosentono H, et al. European Journal of Molecular & Clinical Medicine. 2020; 7 (11) : 709-715.
Download PDF

Publication

Global consultation of National Leprosy Programme managers, partners and affected persons on Global Leprosy Strategy 2021–2030: Report of the virtual meeting 26-30 October 2020

WHO/Department of control of neglected tropical diseases . World Health Organization. 2020;
Download PDF

Publication

Leprosy/Hansen disease: Contact tracing and post-exposure prophylaxis

World Health Organization . World Health Organization. 2020;
Download PDF

Publication

A comprehensive research agenda for zero leprosy

Steinmann P, Dusenbury C, Addiss D, et al. Springer Science and Business Media LLC. Infectious Diseases of Poverty. 2020;
Download PDF

Publication

The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis

Schoenmakers A, Mieras L, Budiawan T, et al. Informa UK Limited. Research and Reports in Tropical Medicine. 2020;
Download PDF

Publication

Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy.

Lenz SM, Collins J, Ray N, et al. PLoS neglected tropical diseases. 2020; 14 (9) : e0008583.
Download PDF

Publication

Jopling's Handbook of Leprosy, 6/E

Sardana K, Khurana A. CBS Publishers & Distributors. 2020;
Download PDF

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Next page Next ›
  • Last page Last »

Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2022 InfoNTD